- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
According to our latest study, the global Favipiravir market size was valued at USD 352.7 million in 2022 and is forecast to a readjusted size of USD 67 million by 2029 with a CAGR of -21.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
This report is a detailed and comprehensive analysis for global Favipiravir market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Favipiravir market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Favipiravir market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Favipiravir market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Favipiravir market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Favipiravir
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Favipiravir market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy and R-Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Favipiravir market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Brand Drug
Generic Drug
Market segment by Application
Influenza Viruses
COVID-19
Others
Major players covered
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Favipiravir product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Favipiravir, with price, sales, revenue and global market share of Favipiravir from 2018 to 2023.
Chapter 3, the Favipiravir competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Favipiravir breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Favipiravir market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Favipiravir.
Chapter 14 and 15, to describe Favipiravir sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Favipiravir
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Favipiravir Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Brand Drug
1.3.3 Generic Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Favipiravir Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Influenza Viruses
1.4.3 COVID-19
1.4.4 Others
1.5 Global Favipiravir Market Size & Forecast
1.5.1 Global Favipiravir Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Favipiravir Sales Quantity (2018-2029)
1.5.3 Global Favipiravir Average Price (2018-2029)
2 Manufacturers Profiles
2.1 ChemRar Group
2.1.1 ChemRar Group Details
2.1.2 ChemRar Group Major Business
2.1.3 ChemRar Group Favipiravir Product and Services
2.1.4 ChemRar Group Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ChemRar Group Recent Developments/Updates
2.2 Glenmark
2.2.1 Glenmark Details
2.2.2 Glenmark Major Business
2.2.3 Glenmark Favipiravir Product and Services
2.2.4 Glenmark Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Glenmark Recent Developments/Updates
2.3 Fujifilm
2.3.1 Fujifilm Details
2.3.2 Fujifilm Major Business
2.3.3 Fujifilm Favipiravir Product and Services
2.3.4 Fujifilm Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fujifilm Recent Developments/Updates
2.4 Dr. Reddy
2.4.1 Dr. Reddy Details
2.4.2 Dr. Reddy Major Business
2.4.3 Dr. Reddy Favipiravir Product and Services
2.4.4 Dr. Reddy Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Dr. Reddy Recent Developments/Updates
2.5 R-Pharma
2.5.1 R-Pharma Details
2.5.2 R-Pharma Major Business
2.5.3 R-Pharma Favipiravir Product and Services
2.5.4 R-Pharma Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 R-Pharma Recent Developments/Updates
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Favipiravir Product and Services
2.6.4 Cipla Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cipla Recent Developments/Updates
2.7 Lupin
2.7.1 Lupin Details
2.7.2 Lupin Major Business
2.7.3 Lupin Favipiravir Product and Services
2.7.4 Lupin Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lupin Recent Developments/Updates
2.8 Sun Pharma
2.8.1 Sun Pharma Details
2.8.2 Sun Pharma Major Business
2.8.3 Sun Pharma Favipiravir Product and Services
2.8.4 Sun Pharma Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sun Pharma Recent Developments/Updates
2.9 Hisun Pharm
2.9.1 Hisun Pharm Details
2.9.2 Hisun Pharm Major Business
2.9.3 Hisun Pharm Favipiravir Product and Services
2.9.4 Hisun Pharm Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hisun Pharm Recent Developments/Updates
3 Competitive Environment: Favipiravir by Manufacturer
3.1 Global Favipiravir Sales Quantity by Manufacturer (2018-2023)
3.2 Global Favipiravir Revenue by Manufacturer (2018-2023)
3.3 Global Favipiravir Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Favipiravir by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Favipiravir Manufacturer Market Share in 2022
3.4.2 Top 6 Favipiravir Manufacturer Market Share in 2022
3.5 Favipiravir Market: Overall Company Footprint Analysis
3.5.1 Favipiravir Market: Region Footprint
3.5.2 Favipiravir Market: Company Product Type Footprint
3.5.3 Favipiravir Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Favipiravir Market Size by Region
4.1.1 Global Favipiravir Sales Quantity by Region (2018-2029)
4.1.2 Global Favipiravir Consumption Value by Region (2018-2029)
4.1.3 Global Favipiravir Average Price by Region (2018-2029)
4.2 North America Favipiravir Consumption Value (2018-2029)
4.3 Europe Favipiravir Consumption Value (2018-2029)
4.4 Asia-Pacific Favipiravir Consumption Value (2018-2029)
4.5 South America Favipiravir Consumption Value (2018-2029)
4.6 Middle East and Africa Favipiravir Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Favipiravir Sales Quantity by Type (2018-2029)
5.2 Global Favipiravir Consumption Value by Type (2018-2029)
5.3 Global Favipiravir Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Favipiravir Sales Quantity by Application (2018-2029)
6.2 Global Favipiravir Consumption Value by Application (2018-2029)
6.3 Global Favipiravir Average Price by Application (2018-2029)
7 North America
7.1 North America Favipiravir Sales Quantity by Type (2018-2029)
7.2 North America Favipiravir Sales Quantity by Application (2018-2029)
7.3 North America Favipiravir Market Size by Country
7.3.1 North America Favipiravir Sales Quantity by Country (2018-2029)
7.3.2 North America Favipiravir Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Favipiravir Sales Quantity by Type (2018-2029)
8.2 Europe Favipiravir Sales Quantity by Application (2018-2029)
8.3 Europe Favipiravir Market Size by Country
8.3.1 Europe Favipiravir Sales Quantity by Country (2018-2029)
8.3.2 Europe Favipiravir Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Favipiravir Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Favipiravir Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Favipiravir Market Size by Region
9.3.1 Asia-Pacific Favipiravir Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Favipiravir Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Favipiravir Sales Quantity by Type (2018-2029)
10.2 South America Favipiravir Sales Quantity by Application (2018-2029)
10.3 South America Favipiravir Market Size by Country
10.3.1 South America Favipiravir Sales Quantity by Country (2018-2029)
10.3.2 South America Favipiravir Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Favipiravir Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Favipiravir Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Favipiravir Market Size by Country
11.3.1 Middle East & Africa Favipiravir Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Favipiravir Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Favipiravir Market Drivers
12.2 Favipiravir Market Restraints
12.3 Favipiravir Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Favipiravir and Key Manufacturers
13.2 Manufacturing Costs Percentage of Favipiravir
13.3 Favipiravir Production Process
13.4 Favipiravir Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Favipiravir Typical Distributors
14.3 Favipiravir Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Favipiravir Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Favipiravir Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ChemRar Group Basic Information, Manufacturing Base and Competitors
Table 4. ChemRar Group Major Business
Table 5. ChemRar Group Favipiravir Product and Services
Table 6. ChemRar Group Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ChemRar Group Recent Developments/Updates
Table 8. Glenmark Basic Information, Manufacturing Base and Competitors
Table 9. Glenmark Major Business
Table 10. Glenmark Favipiravir Product and Services
Table 11. Glenmark Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Glenmark Recent Developments/Updates
Table 13. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 14. Fujifilm Major Business
Table 15. Fujifilm Favipiravir Product and Services
Table 16. Fujifilm Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Fujifilm Recent Developments/Updates
Table 18. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 19. Dr. Reddy Major Business
Table 20. Dr. Reddy Favipiravir Product and Services
Table 21. Dr. Reddy Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Dr. Reddy Recent Developments/Updates
Table 23. R-Pharma Basic Information, Manufacturing Base and Competitors
Table 24. R-Pharma Major Business
Table 25. R-Pharma Favipiravir Product and Services
Table 26. R-Pharma Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. R-Pharma Recent Developments/Updates
Table 28. Cipla Basic Information, Manufacturing Base and Competitors
Table 29. Cipla Major Business
Table 30. Cipla Favipiravir Product and Services
Table 31. Cipla Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cipla Recent Developments/Updates
Table 33. Lupin Basic Information, Manufacturing Base and Competitors
Table 34. Lupin Major Business
Table 35. Lupin Favipiravir Product and Services
Table 36. Lupin Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lupin Recent Developments/Updates
Table 38. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Sun Pharma Major Business
Table 40. Sun Pharma Favipiravir Product and Services
Table 41. Sun Pharma Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sun Pharma Recent Developments/Updates
Table 43. Hisun Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Hisun Pharm Major Business
Table 45. Hisun Pharm Favipiravir Product and Services
Table 46. Hisun Pharm Favipiravir Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hisun Pharm Recent Developments/Updates
Table 48. Global Favipiravir Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Favipiravir Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Favipiravir Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Favipiravir, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Favipiravir Production Site of Key Manufacturer
Table 53. Favipiravir Market: Company Product Type Footprint
Table 54. Favipiravir Market: Company Product Application Footprint
Table 55. Favipiravir New Market Entrants and Barriers to Market Entry
Table 56. Favipiravir Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Favipiravir Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Favipiravir Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Favipiravir Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Favipiravir Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Favipiravir Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Favipiravir Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Favipiravir Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Favipiravir Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Favipiravir Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Favipiravir Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Favipiravir Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Favipiravir Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Favipiravir Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Favipiravir Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Favipiravir Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Favipiravir Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Favipiravir Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Favipiravir Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Favipiravir Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Favipiravir Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Favipiravir Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Favipiravir Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Favipiravir Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Favipiravir Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Favipiravir Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Favipiravir Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Favipiravir Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Favipiravir Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Favipiravir Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Favipiravir Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Favipiravir Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Favipiravir Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Favipiravir Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Favipiravir Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Favipiravir Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Favipiravir Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Favipiravir Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Favipiravir Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Favipiravir Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Favipiravir Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Favipiravir Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Favipiravir Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Favipiravir Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Favipiravir Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Favipiravir Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Favipiravir Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Favipiravir Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Favipiravir Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Favipiravir Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Favipiravir Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Favipiravir Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Favipiravir Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Favipiravir Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Favipiravir Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Favipiravir Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Favipiravir Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Favipiravir Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Favipiravir Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Favipiravir Raw Material
Table 116. Key Manufacturers of Favipiravir Raw Materials
Table 117. Favipiravir Typical Distributors
Table 118. Favipiravir Typical Customers
List of Figures
Figure 1. Favipiravir Picture
Figure 2. Global Favipiravir Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Favipiravir Consumption Value Market Share by Type in 2022
Figure 4. Brand Drug Examples
Figure 5. Generic Drug Examples
Figure 6. Global Favipiravir Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Favipiravir Consumption Value Market Share by Application in 2022
Figure 8. Influenza Viruses Examples
Figure 9. COVID-19 Examples
Figure 10. Others Examples
Figure 11. Global Favipiravir Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Favipiravir Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Favipiravir Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Favipiravir Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Favipiravir Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Favipiravir Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Favipiravir by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Favipiravir Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Favipiravir Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Favipiravir Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Favipiravir Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Favipiravir Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Favipiravir Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Favipiravir Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Favipiravir Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Favipiravir Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Favipiravir Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Favipiravir Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Favipiravir Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Favipiravir Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Favipiravir Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Favipiravir Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Favipiravir Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Favipiravir Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Favipiravir Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Favipiravir Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Favipiravir Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Favipiravir Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Favipiravir Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Favipiravir Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Favipiravir Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Favipiravir Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Favipiravir Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Favipiravir Consumption Value Market Share by Region (2018-2029)
Figure 53. China Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Favipiravir Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Favipiravir Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Favipiravir Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Favipiravir Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Favipiravir Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Favipiravir Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Favipiravir Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Favipiravir Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Favipiravir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Favipiravir Market Drivers
Figure 74. Favipiravir Market Restraints
Figure 75. Favipiravir Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Favipiravir in 2022
Figure 78. Manufacturing Process Analysis of Favipiravir
Figure 79. Favipiravir Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
